vs
Side-by-side financial comparison of Orchid Island Capital, Inc. (ORC) and STEM, INC. (STEM). Click either name above to swap in a different company.
STEM, INC. is the larger business by last-quarter revenue ($47.1M vs $38.5M, roughly 1.2× Orchid Island Capital, Inc.). Orchid Island Capital, Inc. runs the higher net margin — 268.7% vs -33.9%, a 302.6% gap on every dollar of revenue. On growth, Orchid Island Capital, Inc. posted the faster year-over-year revenue change (372.6% vs -15.6%). Over the past eight quarters, Orchid Island Capital, Inc.'s revenue compounded faster (301.6% CAGR vs 36.1%).
Orchid Island Capital, Inc. is a U.S.-based specialty finance company operating as a real estate investment trust. It primarily invests in residential mortgage-backed securities, including agency and non-agency products, targeting consistent risk-adjusted returns for its investors across U.S. fixed income markets.
StemCells, Inc. is a public biopharmaceutical company headquartered in Newark, California, that is developing purified human neural stem cells (HuCNS-SCs) in the hopes of treating central nervous system disorders and paralysis. StemCells' HuCNS-SCs have the ability to differentiate into the three main types of cells found in the central nervous system: neurons, astrocytes and oligodendrocytes.
ORC vs STEM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $38.5M | $47.1M |
| Net Profit | $103.4M | $-16.0M |
| Gross Margin | — | 48.9% |
| Operating Margin | — | -17.7% |
| Net Margin | 268.7% | -33.9% |
| Revenue YoY | 372.6% | -15.6% |
| Net Profit YoY | 1764.9% | 68.8% |
| EPS (diluted) | — | $-4.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $38.5M | $47.1M | ||
| Q3 25 | $26.9M | $38.2M | ||
| Q2 25 | $23.2M | $38.4M | ||
| Q1 25 | $19.7M | $32.5M | ||
| Q4 24 | — | $55.8M | ||
| Q3 24 | $340.0K | $29.3M | ||
| Q2 24 | $-697.0K | $34.0M | ||
| Q1 24 | $-2.5M | $25.5M |
| Q4 25 | $103.4M | $-16.0M | ||
| Q3 25 | $72.1M | $-23.8M | ||
| Q2 25 | $-33.6M | $202.5M | ||
| Q1 25 | $17.1M | $-25.0M | ||
| Q4 24 | — | $-51.1M | ||
| Q3 24 | $17.3M | $-148.3M | ||
| Q2 24 | $-5.0M | $-582.3M | ||
| Q1 24 | $19.8M | $-72.3M |
| Q4 25 | — | 48.9% | ||
| Q3 25 | — | 35.5% | ||
| Q2 25 | — | 33.4% | ||
| Q1 25 | — | 32.4% | ||
| Q4 24 | — | -4.4% | ||
| Q3 24 | — | 21.2% | ||
| Q2 24 | — | 27.6% | ||
| Q1 24 | — | -95.0% |
| Q4 25 | — | -17.7% | ||
| Q3 25 | — | -33.6% | ||
| Q2 25 | — | -34.8% | ||
| Q1 25 | — | -65.0% | ||
| Q4 24 | — | -84.4% | ||
| Q3 24 | — | -493.2% | ||
| Q2 24 | — | -1705.5% | ||
| Q1 24 | — | -267.0% |
| Q4 25 | 268.7% | -33.9% | ||
| Q3 25 | 267.8% | -62.2% | ||
| Q2 25 | -145.0% | 527.8% | ||
| Q1 25 | 86.9% | -76.9% | ||
| Q4 24 | — | -91.6% | ||
| Q3 24 | 5094.1% | -506.3% | ||
| Q2 24 | 714.3% | -1712.6% | ||
| Q1 24 | -794.2% | -283.9% |
| Q4 25 | — | $-4.40 | ||
| Q3 25 | — | $-2.84 | ||
| Q2 25 | — | $-1.79 | ||
| Q1 25 | — | $-0.15 | ||
| Q4 24 | — | $-15.29 | ||
| Q3 24 | — | $-18.24 | ||
| Q2 24 | — | $-71.81 | ||
| Q1 24 | — | $-0.46 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $665.9M | $48.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.4B | $-249.4M |
| Total Assets | $11.7B | $308.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $665.9M | $48.9M | ||
| Q3 25 | $583.9M | $43.1M | ||
| Q2 25 | $440.8M | $40.8M | ||
| Q1 25 | $396.4M | $58.6M | ||
| Q4 24 | — | $56.3M | ||
| Q3 24 | $322.1M | $75.4M | ||
| Q2 24 | $241.0M | $89.6M | ||
| Q1 24 | $190.4M | $112.8M |
| Q4 25 | $1.4B | $-249.4M | ||
| Q3 25 | $1.1B | $-235.7M | ||
| Q2 25 | $912.0M | $-214.1M | ||
| Q1 25 | $855.9M | $-417.5M | ||
| Q4 24 | — | $-398.4M | ||
| Q3 24 | $656.0M | $-344.1M | ||
| Q2 24 | $555.9M | $-203.2M | ||
| Q1 24 | $481.6M | $371.6M |
| Q4 25 | $11.7B | $308.9M | ||
| Q3 25 | $9.1B | $362.6M | ||
| Q2 25 | $7.6B | $379.2M | ||
| Q1 25 | $7.3B | $405.1M | ||
| Q4 24 | — | $437.4M | ||
| Q3 24 | $5.9B | $537.8M | ||
| Q2 24 | $4.9B | $691.5M | ||
| Q1 24 | $4.2B | $1.3B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $120.4M | $8.2M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 1.16× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $120.4M | $8.2M | ||
| Q3 25 | $28.0M | $11.4M | ||
| Q2 25 | $18.4M | $-21.3M | ||
| Q1 25 | $25.8M | $8.5M | ||
| Q4 24 | — | $-14.7M | ||
| Q3 24 | $-14.8M | $-9.4M | ||
| Q2 24 | $19.3M | $-11.9M | ||
| Q1 24 | $45.0M | $-621.0K |
| Q4 25 | 1.16× | — | ||
| Q3 25 | 0.39× | — | ||
| Q2 25 | — | -0.11× | ||
| Q1 25 | 1.51× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -0.86× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 2.28× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
